GNMX
Corgi Genomics & Precision Medicine ETF
GNMX
Closed
$31.55
Closed
-(-)
At close
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply
About
GNMX was created on 2026-05-06 by Corgi. The fund's investment portfolio concentrates primarily on theme equity. The ETF currently has 1.64m in AUM and 60 holdings. GNMX seeks capital appreciation through a portfolio of companies tiedto thegenomics and precision medicine value chain, from sequencing platforms and bioinformatics engines to gene editors, molecular diagnostics, targeted therapies, and clinical data platforms.
Company
Corgi
Asset class
Equity
Inception date
2026
Investment segment
Theme
ISIN
US2189468463
Website
Key stats
Open
$31.61
Volume
194.00
AUM
$1.73M
Prev. close
$32.07
Expense ratio
0.35%
P/E
0.00
$31.55
Day’s Range
$31.64
$23.88
52W Range
$32.07
What’s in the fund
60
Total holdings
Thermo Fisher Scientific Inc
7.82%
Vertex Pharmaceuticals Inc
6.64%
Guardant Health Inc
4.23%
Illumina Inc
3.85%
Alnylam Pharmaceuticals Inc
3.83%
Moderna Inc
3.82%
Revolution Medicines Inc Ordinary Shares
3.69%
Incyte Corp
3.03%
Genmab AS ADR
2.67%
Others
60.42%
Returns
Performance
_
Difference
_
Corgi Genomics & Precision Medicine ETF
Get professional financial guidance
Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply